Pages
(Move to ...)
Home
▼
Showing posts with label
gene therapy
.
Show all posts
Showing posts with label
gene therapy
.
Show all posts
Friday, February 07, 2014
These Days, You Can't Spell Financings Of The Fortnight Without "I-P-O"
›
It turns out a lot of the words that contain the letters "IPO" are biomedical words: Pluripotent. Liposomal. Adiposis. Galli...
Monday, December 16, 2013
2013 Financing of the Year Nominee: CHOP Launches Spark
›
It's time for the IN VIVO Blog's Sixth Annual Deal of the Year! competition. This year we're once again presenting awards in th...
2013 Financing of the Year Nominee: Editas
›
It's time for the IN VIVO Blog's Sixth Annual Deal of the Year! competition. This year we're once again presenting awards in th...
Friday, December 06, 2013
Deals Of The Week Looks At Pricing Conundrums
›
Some technologies are so unprecedented, so spanking new that they present hitherto unknown and formidable commercial hurdles. Consider ...
Friday, November 01, 2013
Single, Early-Stage Financings of the Fortnight Seeks Attractive Exit Correlation
›
One month ago, as the government shut itself partially down, this column wondered if the IPO window might undergo a similar fate. Sinc...
›
Home
View web version
